These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 17967730)

  • 21. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
    Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
    J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.
    Gulli F; Napodano C; Marino M; Ciasca G; Pocino K; Basile V; Visentini M; Stefanile A; Todi L; De Spirito M; Rapaccini GL; Basile U
    Clin Exp Immunol; 2020 Feb; 199(2):163-171. PubMed ID: 31618438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies in pre-clinical autoimmune disease.
    Hu ZD; Deng AM
    Clin Chim Acta; 2014 Nov; 437():14-8. PubMed ID: 24972003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L; Nozzi M; De Sanctis S; Chiarelli F
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality in autoimmune rheumatic diseases with anti-Ro/SSA antibody in Korea: Single center-based retrospective study.
    Kim SK; Choe JY; Kwak SG
    Int J Rheum Dis; 2019 Feb; 22(2):191-199. PubMed ID: 30398019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.
    Giacomelli R; Afeltra A; Alunno A; Baldini C; Bartoloni-Bocci E; Berardicurti O; Carubbi F; Cauli A; Cervera R; Ciccia F; Cipriani P; Conti F; De Vita S; Di Benedetto P; Doria A; Drosos AA; Favalli EG; Gandolfo S; Gatto M; Grembiale RD; Liakouli V; Lories R; Lubrano E; Lunardi C; Margiotta DPE; Massaro L; Meroni P; Minniti A; Navarini L; Pendolino M; Perosa F; Pers JO; Prete M; Priori R; Puppo F; Quartuccio L; Ruffatti A; Ruscitti P; Russo B; Sarzi-Puttini P; Shoenfeld Y; Somarakis GA; Spinelli FR; Tinazzi E; Triolo G; Ursini F; Valentini G; Valesini G; Vettori S; Vitali C; Tzioufas AG
    Autoimmun Rev; 2017 Sep; 16(9):911-924. PubMed ID: 28705780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
    Ramos-Casals M; Brito-Zerón P; Font J
    Semin Arthritis Rheum; 2007 Feb; 36(4):246-55. PubMed ID: 16996579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The challenge of identification of autoantibodies specific to systemic autoimmune rheumatic diseases in high throughput operation: proposal of reliable and feasible strategies.
    Pereira KM; Dellavance A; Andrade LE
    Clin Chim Acta; 2014 Nov; 437():203-10. PubMed ID: 25091804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases.
    Bernatsky S; Linehan T; Hanly JG
    J Rheumatol; 2011 Aug; 38(8):1612-6. PubMed ID: 21532057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of indirect immunofluorescence and line immunoassay for autoantibody detection.
    Jeon YL; Kim MH; Lee WI; Kang SY
    Clin Exp Rheumatol; 2013; 31(1):84-90. PubMed ID: 23043859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases.
    Abrão AL; Santana CM; Bezerra AC; Amorim RF; Silva MB; Mota LM; Falcão DP
    Rev Bras Reumatol Engl Ed; 2016; 56(5):441-450. PubMed ID: 27692394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.
    Muro Y; Nakanishi H; Katsuno M; Kono M; Akiyama M
    Clin Chim Acta; 2017 Sep; 472():1-4. PubMed ID: 28687351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease.
    Hafiz W; Nori R; Bregasi A; Noamani B; Bonilla D; Lisnevskaia L; Silverman E; Bookman AAM; Johnson SR; Landolt-Marticorena C; Wither J
    Arthritis Res Ther; 2019 Nov; 21(1):223. PubMed ID: 31685018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New concepts in systemic autoimmunity testing.
    Lehmann HP; Block D; Markert-Hahn C; Zolg JW
    Scand J Clin Lab Invest Suppl; 2001; 235():84-90. PubMed ID: 11712697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.
    Nozawa K; Doe K; Uomori K; Sekigawa I; Takasaki Y; Yamaji K; Tamura N
    Autoimmunity; 2017 Jun; 50(4):241-246. PubMed ID: 28553742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease.
    Baglaenko Y; Chang NH; Johnson SR; Hafiz W; Manion K; Ferri D; Noamani B; Bonilla D; Rusta-Sellehy S; Lisnevskaia L; Silverman E; Bookman A; Landolt-Marticorena C; Wither J
    Arthritis Res Ther; 2018 Nov; 20(1):264. PubMed ID: 30486869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
    Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
    Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in systemic sclerosis.
    Mehra S; Walker J; Patterson K; Fritzler MJ
    Autoimmun Rev; 2013 Jan; 12(3):340-54. PubMed ID: 22743034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.